Atlas Trials

MK0524B Bioequivalence Study (0524B-070)

Clinical trial NCT00943124 · COMPLETED

Trial details

NCT number
NCT00943124
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2007-07-01
Primary completion
2007-08-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.